{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:06:33Z","timestamp":1770836793716,"version":"3.50.1"},"reference-count":90,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In the context of the COVID-19 pandemic, this study investigates the potential correlation between the increased use of antipsychotic medications and the rising incidence of venous thromboembolism (VTE). As psychiatric disorders surged, the consequential escalation in antipsychotic drug use raised concerns about thrombotic risks. We conducted a comprehensive literature review using PubMed, focusing on articles that intersected COVID-19, antipsychotic medication, and thrombosis. This approach allowed for a nuanced examination of the historical and recent data on antipsychotic drugs and their association with thrombotic events. Our findings reveal a notable link between the use of antipsychotic medications, particularly second-generation antipsychotics, and an increased risk of VTE, including pulmonary embolism and deep vein thrombosis. This association was evident, despite variations in study designs and populations. The study underscores the need for cautious medication management in psychiatric care, especially during pandemic conditions like COVID-19, to mitigate thrombotic risks. It advocates a personalized approach to prescribing antipsychotics, considering individual patient factors and comorbidities, to balance the benefits against potential thrombotic complications.<\/jats:p>","DOI":"10.3390\/ijms25020818","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T04:38:51Z","timestamp":1704775131000},"page":"818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 and Antipsychotic Therapy: Unraveling the Thrombosis Risk"],"prefix":"10.3390","volume":"25","author":[{"given":"Eszter-Anna","family":"Dho-Nagy","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine in English, Preclinical Research Laboratory, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Brassai","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine in English, Preclinical Research Laboratory, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lechsner","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine in English, Preclinical Research Laboratory, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"Ureche","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7520-1454","authenticated-orcid":false,"given":"Erika-Gy\u00f6ngyi","family":"B\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine in English, Preclinical Research Laboratory, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"105534","DOI":"10.1016\/j.phrs.2021.105534","article-title":"Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications","volume":"167","author":"Harrison","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bliek-Bueno, K., Mucherino, S., Poblador-Plou, B., Gonz\u00e1lez-Rubio, F., Aza-Pascual-Salcedo, M., Orlando, V., Clerencia-Sierra, M., Ioakeim-Skoufa, I., Coscioni, E., and Carmona-P\u00edrez, J. (2021). Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182211786"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.acvd.2023.11.009","article-title":"Management of cancer-associated thromboembolism in vulnerable population","volume":"117","author":"Laporte","year":"2024","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.acvd.2023.11.012","article-title":"Home treatment for patients with cancer-associated venous thromboembolism","volume":"117","author":"Sanchez","year":"2024","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11795549231220297","DOI":"10.1177\/11795549231220297","article-title":"Cancer-Associated Thrombosis: Epidemiology, Pathophysiological Mechanisms, Treatment, and Risk Assessment","volume":"17","author":"Pavlovic","year":"2023","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"IV-4","DOI":"10.1161\/01.CIR.0000150639.98514.6c","article-title":"Prevention of venous thromboembolism in surgical patients","volume":"110","author":"Agnelli","year":"2004","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/SLA.0000000000006096","article-title":"An Updated Systematic Review and Meta-analysis of the Impact of Graduated Compression Stockings in Addition to Pharmacological Thromboprophylaxis for Prevention of Venous Thromboembolism in Surgical Inpatients","volume":"279","author":"Turner","year":"2024","journal-title":"Ann. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_9","first-page":"224","article-title":"Thrombosis hazard in chlorpromazine and reserpine therapy of endogenous psychoses","volume":"30","author":"Grahmann","year":"1959","journal-title":"Nervenarzt"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"103105","DOI":"10.1016\/j.ajp.2022.103105","article-title":"Fatal pulmonary embolism in patients on antipsychotics: Case series, systematic review and meta-analysis","volume":"73","author":"Manoubi","year":"2022","journal-title":"Asian J. Psychiatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5694\/j.1326-5377.1976.tb130327.x","article-title":"Treatment of calcinosis circumscripta and Raynaud\u2019s phenomenon","volume":"2","author":"Meyers","year":"1976","journal-title":"Med. J. Aust."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0954-6820.1980.tb10952.x","article-title":"Possible approaches to the pharmacological prevention of myocardial ischaemia","volume":"642","author":"Born","year":"1980","journal-title":"Acta Med. Scand. Suppl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/2161126a0","article-title":"Filling gaps in the vascular endothelium with blood platelets","volume":"216","author":"Tranzer","year":"1967","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.179.1.63","article-title":"Antipsychotic medication and venous thrombosis","volume":"179","author":"Thomassen","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0033-3182(83)73114-2","article-title":"Deep-vein thrombosis with antipsychotic drugs","volume":"24","author":"Varia","year":"1983","journal-title":"Psychosomatics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40264-014-0170-y","article-title":"Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies","volume":"37","author":"Sultana","year":"2014","journal-title":"Drug Saf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2014.12.042","article-title":"Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy","volume":"162","author":"Chow","year":"2015","journal-title":"Schizophr. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/pds.2210","article-title":"Antipsychotic drugs and risk of pulmonary embolism","volume":"21","author":"Allenet","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12656","DOI":"10.4088\/JCP.18m12656","article-title":"The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study","volume":"80","author":"Ferraris","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"ref_20","first-page":"e16883","article-title":"Clozapine-Related Thromboembolic Events","volume":"13","author":"Dave","year":"2021","journal-title":"Cureus"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Reponen, E.J., Ueland, T., Rokicki, J., Bettella, F., Aas, M., Werner, M.C.F., Dieset, I., Steen, N.E., Andreassen, O.A., and Tesli, M. (2023). Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers. Eur. Arch. Psychiatry Clin. Neurosci., 273, Online ahead of print.","DOI":"10.1007\/s00406-023-01591-0"},{"key":"ref_22","first-page":"998","article-title":"Deep vein thrombosis in the psychiatric patients under physical restraint","volume":"109","author":"Nishio","year":"2007","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11739-023-03228-5","article-title":"Post-COVID condition: Dispensation of drugs and diagnostic tests as proxies of healthcare impact","volume":"18","author":"Nobili","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"ref_24","first-page":"466","article-title":"Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations","volume":"18","author":"Ostuzzi","year":"2020","journal-title":"BMC Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2023.2251881","article-title":"A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data","volume":"22","author":"Yan","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1345\/aph.1E021","article-title":"Fatal venous thromboembolism associated with antipsychotic therapy","volume":"38","author":"Farah","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"ref_27","first-page":"421","article-title":"Risk and prophylaxis of venous thromboembolism in hospitalized psychiatric patients. A review","volume":"52","author":"Wilkowska","year":"2018","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1472-8206.2007.00515.x","article-title":"Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: Results from the EDITH case-control study","volume":"21","author":"Lacut","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/YCO.0000000000000403","article-title":"Sudden death in schizophrenia","volume":"31","author":"Li","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"113691","DOI":"10.1016\/j.psychres.2020.113691","article-title":"Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis","volume":"296","author":"Di","year":"2021","journal-title":"Psychiatry Res.-Neuroimaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2015.01.012","article-title":"A population-based cohort study on deep vein thrombosis and pulmonary embolism among schizophrenia patients","volume":"162","author":"Hsu","year":"2015","journal-title":"Schizophr. Res."},{"key":"ref_32","first-page":"299","article-title":"Olanzapine and venous thromboembolism","volume":"18","author":"Spigset","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.4088\/JCP.v65n1122b","article-title":"A case of venous thromboembolism probably associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics","volume":"65","author":"Toki","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2666-7568(20)30063-5","article-title":"Antipsychotic use and psychiatric disorders in COVID-19","volume":"2","author":"Ferraris","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e239569","DOI":"10.1136\/bcr-2020-239569","article-title":"Deep vein thrombosis on the fourth day of risperidone therapy","volume":"14","author":"George","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1108\/MIJ-10-2019-0005","article-title":"Case report: Chlorpromazine and deep venous thrombosis","volume":"11","author":"Reed","year":"2019","journal-title":"Ment. Illn."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13256-021-02865-8","article-title":"Central retinal vein occlusion in a patient using the antipsychotic drug olanzapine: A case report","volume":"15","author":"Nowrouzi","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jemermed.2018.10.036","article-title":"Cerebral Venous Thrombosis: An Uncommon Cause of Papilledema on Bedside Ocular Ultrasound","volume":"56","author":"Arthur","year":"2019","journal-title":"J. Emerg. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/JCP.0b013e3181deb88a","article-title":"Clozapine-associated cerebral venous thrombosis","volume":"30","author":"Srinivasaraju","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JCP.0000000000001156","article-title":"Acute Bilateral Coronary Artery Thrombosis and Myocardial Infarction in a 25-Year-Old Man After Long-Term Oral Clozapine Treatment","volume":"40","author":"Wang","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1097\/MJT.0000000000000994","article-title":"Olanzapine-Associated Portal and Superior Mesenteric Vein Thrombosis","volume":"27","author":"Mameli","year":"2020","journal-title":"Am. J. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"c4245","DOI":"10.1136\/bmj.c4245","article-title":"Antipsychotic drugs and risk of venous thromboembolism: Nested case-control study","volume":"341","author":"Parker","year":"2010","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1176\/appi.ajp.2013.13040494","article-title":"Pulmonary embolism in a psychiatric patient","volume":"171","author":"Barnhorst","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fpsyt.2019.00330","article-title":"Venous Thromboembolism as an Adverse Effect During Treatment With Olanzapine: A Case Series","volume":"10","author":"Masopust","year":"2019","journal-title":"Front. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20451253231200257","DOI":"10.1177\/20451253231200257","article-title":"Hypercoagulable state in patients with schizophrenia: Different effects of acute and chronic antipsychotic medications","volume":"13","author":"Zheng","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.9740\/mhc.2018.03.068","article-title":"Assessment of venous thromboembolism risk and initiation of appropriate prophylaxis in psychiatric patients","volume":"8","author":"Ruhe","year":"2018","journal-title":"Ment. Health Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/archinte.165.22.2677","article-title":"Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents","volume":"165","author":"Liperoti","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11319120-000000000-00000","article-title":"Cerebrovascular accidents in elderly people treated with antipsychotic drugs: A systematic review","volume":"33","author":"Sacchetti","year":"2010","journal-title":"Drug Saf."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(00)02784-7","article-title":"Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: A case-control study","volume":"356","author":"Zornberg","year":"2000","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.2830270408","article-title":"Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis","volume":"27","author":"Canoso","year":"1988","journal-title":"Am. J. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection","volume":"24","author":"Pons","year":"2020","journal-title":"Crit. Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.31083\/j.rcm.2020.03.126","article-title":"Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy","volume":"21","author":"Zhang","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"136093","DOI":"10.1016\/j.neulet.2021.136093","article-title":"Involvement of vascular endothelial growth factor in schizophrenia","volume":"760","author":"Rampino","year":"2021","journal-title":"Neurosci. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jorgensen, A., Knorr, U., Soendergaard, M.G., Lykkesfeldt, J., Fink-Jensen, A., Poulsen, H.E., Jorgensen, M.B., Olsen, N.V., and Staals\u00f8, J.M. (2015). Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: A case\u2013control study. BMC Psychiatry, 15.","DOI":"10.1186\/s12888-015-0455-4"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/a-0991-7684","article-title":"Clozapine Disrupts Endothelial Nitric Oxide Signaling and Antioxidant System for its Cardiovascular Complications","volume":"69","author":"Nair","year":"2019","journal-title":"Drug Res."},{"key":"ref_56","first-page":"e719395","article-title":"Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis","volume":"2014","author":"Murphy","year":"2014","journal-title":"Schizophr. Res. Treat."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00406-017-0842-6","article-title":"Abnormal levels of vascular endothelial biomarkers in schizophrenia","volume":"268","author":"Nguyen","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psychres.2015.04.020","article-title":"Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment","volume":"228","author":"Lee","year":"2015","journal-title":"Psychiatry Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pnpbp.2018.05.005","article-title":"Vascular endothelial growth factor in patients with schizophrenia: A systematic review and meta-analysis","volume":"86","author":"Misiak","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijbiomac.2020.03.119","article-title":"Atypical antipsychotic clozapine binds fibrinogen and affects fibrin formation","volume":"154","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2004-825727","article-title":"Co-activation of platelets by prolactin or leptin--pathophysiological findings and clinical implications","volume":"36","author":"Wallaschofski","year":"2004","journal-title":"Horm. Metab. Res."},{"key":"ref_62","first-page":"263","article-title":"Venous thrombosis during olanzapine treatment: A complex association","volume":"76","author":"Dijkstra","year":"2018","journal-title":"Neth. J. Med."},{"key":"ref_63","first-page":"412","article-title":"Incidence and prevention of deep vein thrombosis in restrained psychiatric patients","volume":"30","author":"Therasse","year":"2018","journal-title":"Psychiatr. Danub."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"85.e5","DOI":"10.1016\/j.genhosppsych.2010.11.010","article-title":"Nonfatal pulmonary embolus associated with clozapine treatment: A case series","volume":"33","author":"Tripp","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11096-018-0599-7","article-title":"Venous thromboembolism prophylaxis in mental health in-patient services: A qualitative study","volume":"40","author":"Purcell","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/NDT.S243308","article-title":"Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients","volume":"16","author":"Takeshima","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00414-012-0670-1","article-title":"Fatal thromboembolism following physical restraint in a patient with schizophrenia","volume":"126","author":"Cecchi","year":"2012","journal-title":"Int. J. Legal Med."},{"key":"ref_68","first-page":"2294","article-title":"[Deep venous thrombosis and fatal pulmonary embolism in a physically restrained patient]","volume":"167","author":"Nielsen","year":"2005","journal-title":"Ugeskr. Laeger"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1757-1626-3-36","article-title":"Olanzapine and pulmonary embolism, a rare association: A case report","volume":"3","author":"Maempel","year":"2010","journal-title":"Cases J."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Yong, K.C., Kah, T.A., Ghee, Y.T., Siang, L.C., and Bastion, M.-L.C. (2011). Branch retinal vein occlusion associated with quetiapine fumarate. BMC Ophthalmol., 11.","DOI":"10.1186\/1471-2415-11-24"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/JCP.0b013e3181f0e87d","article-title":"Antipsychotic drug use and the risk of venous thromboembolism in elderly patients","volume":"30","author":"Kleijer","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0037-1613188","article-title":"Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism","volume":"88","author":"Ray","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/15622975.2017.1285048","article-title":"Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme","volume":"19","author":"Letmaier","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2516.2000.00450.x","article-title":"Acquired haemophilia in recipients of depot thioxanthenes","volume":"6","author":"Stewart","year":"2000","journal-title":"Haemophilia"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"bcr0720114542","DOI":"10.1136\/bcr.07.2011.4542","article-title":"An unusual presentation of cortical venous thrombosis and its association with typical antipsychotics","volume":"2011","author":"Andole","year":"2011","journal-title":"BMJ Case Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s11739-023-03375-9","article-title":"Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: A prospective single-centre cohort study","volume":"18","author":"Catalani","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0042-1749441","article-title":"Platelet Activation and Thrombosis in COVID-19","volume":"49","author":"Iba","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/00033197231153204","article-title":"Vascular \u201cLong COVID\u201d: A New Vessel Disease?","volume":"75","author":"Zanini","year":"2024","journal-title":"Angiology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2022.02.016","article-title":"COVID-19 and thrombosis: The role of hemodynamics","volume":"212","author":"Sastry","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.thromres.2021.04.012","article-title":"COVID-19 and thrombotic microangiopathies","volume":"202","author":"Tiwari","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Babkina, A.S., Yadgarov, M.Y., Volkov, A.V., Kuzovlev, A.N., Grechko, A.V., and Golubev, A.M. (2023). Spectrum of Thrombotic Complications in Fatal Cases of COVID-19: Focus on Pulmonary Artery Thrombosis In Situ. Viruses, 15.","DOI":"10.3390\/v15081681"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"100761","DOI":"10.1016\/j.blre.2020.100761","article-title":"Coagulation and anticoagulation in COVID-19","volume":"47","author":"Hadid","year":"2021","journal-title":"Blood Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tcm.2020.12.004","article-title":"COVID-19 and thrombosis: From bench to bedside","volume":"31","author":"Ali","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1\u20137)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/02683555211052170","article-title":"COVID-19 related thrombosis: A mini-review","volume":"37","author":"Cheng","year":"2022","journal-title":"Phlebology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"d4656","DOI":"10.1136\/bmj.d4656","article-title":"Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: Prospective cohort study","volume":"343","author":"Coupland","year":"2011","journal-title":"BMJ"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/bcp.14560","article-title":"Development and validation of the Adverse Inpatient Medication Event model (AIME)","volume":"87","author":"Falconer","year":"2021","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:42:50Z","timestamp":1760103770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25020818"],"URL":"https:\/\/doi.org\/10.3390\/ijms25020818","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}